Tackling Trauma with Pharmahuasca and DMT
Psychedelics may hold the key to a novel PTSD treatment.
Plants, Substances and Products
COMPASS Patent Challenge Targets Crystallography Errors
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Psychedelics and Substance Use Disorder: 4000 BCE to Present Day
The therapeutic uses of psychedelics were discovered over 6,000 years ago, but recent scientific exploration brings them to the mainstream.
Editor’s Choice Award 2021-Best Study on Psychedelics and Nature
The pace of psychedelic research continued its acceleration during 2021, culminating in several fascinating and groundbreaking studies. As the year comes to a close, Psychedelic Science Review is acknowledging some...
Ibogaine and Cardiac Arrhythmia: The Heart of the Matter
Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
The Serotonin 5-HT2A Receptor: From Mice to Humans
Although there are distinct differences between our species, the mouse serotonin 2A receptor plays a crucial role in human psychedelic drug research.
The Missing Mushroom: Psychedelic Science and the Future of Psilocybin
Scientists know there’s more to magic mushrooms than just psilocybin. But as the psychedelic industry begins taking shape, could the mushroom itself be left behind?
The Compounds in Psychedelic Cacti
Mescaline is the best-known phenethylamine in psychedelic cacti; but what about the other “minor” compounds in those cacti?
More Evidence of the Chemical Compound Variability in Magic Mushrooms
Data released by Filament Health shows why it’s important to understand the basic chemical makeup of magic mushrooms.
Are Prodrugs the Next Wave of Psychedelic Drug Development?
The path toward therapeutic psychedelic-based drugs is becoming clearer as scientists understand more about how they are processed in the body.